Publication | Closed Access

Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: A role for serotonin 5-HT1A receptors

NeuropsychologyPsychoactive DrugCognitive NeuroscienceMedicineSerotonin 5-Ht1a ReceptorsPhencyclidine-induced Cognitive DeficitsPsychopharmacologyNeuropharmacologyPharmacotherapyNeuroscienceDopaminePharmacologySocial Sciences